Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification is a Poor Prognostic Factor in Osteosarcoma.
Amanda E. Marinoff,Liam F. Spurr,Christina Fong,Yvonne Y. Li,Suzanne J. Forrest,Abigail Ward,Duong Doan,Laura Corson,Audrey Mauguen,Navin Pinto,Luke Maese,Susan Colace,Margaret E. Macy,Aerang Kim,Amit J. Sabnis,Mark A. Applebaum,Theodore W. Laetsch,Julia Glade-Bender,Daniel A. Weiser,Megan Anderson,Brian D. Crompton,Paul Meyers,Ahmet Zehir,Laura Macconaill,Neal Lindeman,Jonathan A. Nowak,Marc Ladanyi,Alanna J. Church,Andrew D. Cherniack,Neerav Shukla,Katherine A. Janeway JCO precision oncology（2023）
AI 理解论文
溯源树
样例
